Compare ARBB & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARBB | BRTX |
|---|---|---|
| Founded | 1997 | 1997 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Managed Health Care |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2M | 9.7M |
| IPO Year | 2023 | N/A |
| Metric | ARBB | BRTX |
|---|---|---|
| Price | $6.76 | $1.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 48.3K | ★ 80.7K |
| Earning Date | 11-03-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $46,842,655.00 | $383,400.00 |
| Revenue This Year | N/A | $112.14 |
| Revenue Next Year | $24.79 | $139.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 239.12 | 1.70 |
| 52 Week Low | $3.92 | $0.98 |
| 52 Week High | $18.60 | $2.55 |
| Indicator | ARBB | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.27 | 42.29 |
| Support Level | $5.60 | $0.98 |
| Resistance Level | $7.15 | $1.11 |
| Average True Range (ATR) | 0.55 | 0.13 |
| MACD | 0.13 | -0.00 |
| Stochastic Oscillator | 64.12 | 36.07 |
ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.